Introduction
rizes the present knowledge about effects of exogenous ?
and endogenous NO on myocardial functions such as
?
Nitrogen monoxide (nitric oxide, NO) represents an contraction, relaxation and beating rate. It is focused on important mediator within the cardiovascular system.
investigations of isolated cells, tissues and in vivo set-ups
Chemically, NO is a lipophilic, highly reactive and in animals and man under basal conditions. The interacunstable gaseous molecule. It is liberated from organic tions between sympathoadrenal stimulation of the heart ? nitrates and other nitrovasodilators as the pharmacologicaland myocardial effects of NO, which have already been ly active principle of these drugs and has a therapeutic extensively reviewed [10, 11] , are discussed only briefly. potential that has been in use for decades [1] . Ten years ? ago, it became evident that NO is produced by different ? ?
NO-synthase (NOS) isozymes in the body [2] . Two of 2. Exogenous NO these enzymes, the endothelial (eNOS) and the neuronal (nNOS) isoform are constitutively expressed, while the Most of the present knowledge about the effects of necrosis factor a [3] . regarding the mechanism and kinetics of NO release and
Endogenous production of NO is involved in a variety the generation of toxic side products during degradation. of physiological functions, such as local and systemic
The group of nitrovasodilators comprises compounds with regulation of vascular tone, regulation of immune defense, very heterogeneous chemical structures, such as organic synaptic plasticity and other neurologic functions [4] [5] [6] .
nitrates and nitrites, 3- following reperfusion after stroke [7] [8] [9] . By contrast, other ER / NO ) or sodium (Z)-1-(N,N-diethylamino)diazen- 1-? pathologic conditions have been shown to be associated ium-1,2-diolat (DEA / NO).
?
with a decreased capacity of normal vascular NO syn-
thesis or an impairment of its physiologic effects as 2.1. NO, NO-donors , organic nitrates measured by blunted endothelium-dependent vasorelaxa-? tion. These conditions include coronary artery disease, Exogenous NO, delivered by organic nitrates, has been hypertension, diabetes and heart failure [4] .
used for more than 100 years as a remedy to relieve
In contrast to numerous investigations on the effects of pectanginal pain [12] . By contrast, the NO-donating ? NO on vascular smooth muscle, its actions on the cardiac properties of these drugs were discovered much later [1] .
? muscle and the conduction system of the heart has only contrast, N-nitroso derivatives, the so-called NOates, are cium channels [38] , but so far, there are no data supporting exclusively used in experimental medicine. DEA / NO and this hypothesis. SPER / NO are stable in alkaline solutions but spontaneous-
The second major target protein of cGMP is the PDE III ly degrade with different half-lives at physiological pH, [27] . This enzyme is an important type of phosphodies-
giving a total of 2 mol of NO per mol of compound [23] . terase in mammalian cardiomyocytes [39] . Activation of So far, there is no evidence demonstrating the generation PDE III has been observed at low concentrations of cGMP of toxic or any other interfering side products during the (,1 mM). Binding of cGMP to PDE III reduces the spontaneous degradation of these compounds. Another activity of the enzyme and subsequently results in a ?
advantage of NOates is their well-defined half-life in measurable increase of the cAMP content of caraqueous solutions under physiological conditions. diomyocytes [40] . Earlier investigations in frog and guinea L-type calcium channels. NO is also able to directly inhibit L-type calcium channels or to diminish mitochondrial ATP synthesis.
? pig cardiomyocytes have shown that inhibition of PDE III 2.2.2. cGMP-independent NO-signalling pathways initiated by cGMP stimulates transmembrane calcium NO might influence the function of cardiac muscle by current [33, 36] . A similar effect was shown to occur in signalling pathways that circumvent the generation of myocytes derived from human atrial tissue [28] . InterestcGMP by soluble guanylate cyclase [10] . Indeed, two ingly, inhibition of PDE III by 8-bromo-cGMP in intact recent studies provided evidence for such pathways in tissues is unlikely, because this widely used cGMP anacardiomyocytes. Investigations of the oxygen consumption ? logue is a ten-fold stronger stimulator of PKG but a of isolated dog ventricular tissue have shown that the NO 60-fold weaker inhibitor of PDE III compared with cGMP donor SNAP can inhibit cellular respiration [25] . This [41] . effect, which occurs at a SNAP concentration below 1 mM, was suggested to be the consequence of an inhibition of observed in rat constant-flow Langendorff preparations and mitochondrial electron transport. Another signalling pathcat papillary muscle [47, 48] . Subjection of rabbit papillary ?
way that was independent of cGMP was reported by Hu et muscle to a very high concentration (100 mM) of NO in al. [42] . showed that exogenous NO is capable of reducing the approach is to compensate for the nitrate-induced hemocontractile response of ventricular muscle to electrical field dynamic effect by volume loading before measurement of stimulation [46] . A similar result was obtained after changes of myocardial contractility is performed. Using subjection of the same cell type to high concentrations of this method, direct positive inotropic effects of GTN were effect. However, the inotropic effects of NO in isolated NO derived from studies with ferret papillary muscle [54] . cardiomyocytes were small compared to the effects of The relaxation-hastening effect also induced a reduction in catecholamines.
peak tension developed during ventricular contraction but
Small effects of NO on myocardial contractility were had no effect on dP/dt . A lusitropic action was also max also found in various studies with isolated cardiac muscle seen after direct activation of PKG by 8-bromo-cGMP. and Langendorff preparations. Investigations in rat papilFurther investigations in isolated cardiomyocytes, guinea ? lary muscle with NO concentrations below 1 mM showed pig working hearts and constant flow perfused rat hearts a small increase in twitch tension between 12 and 15% confirmed these interesting results [37, 55, 56] . A similar ? [40] . In accordance, maximal inotropic effects of NO relaxation-hastening effect was observed in patients with donors, not exceeding a 15% increase in contractility, were coronary artery disease after intracoronary infusion of SNP ? [57] . The underlying mechanism might involve an activa- L-arginine to citrulline, indicating the presence of a confailed to detect an influence on the contractile response to stitutive NOS. Furthermore, pretreatment of rats with electrical field stimulation [59, 64] . By contrast, studies in various cytokines for 6 h resulted in a great increase in spontaneously beating or paced multicellular preparations calcium-independent NOS activity, which is typical for of ventricular myocardium showed that pharmacological induction of iNOS. Another study confirmed and extended inhibition of NOS decreases myocardial contractility. This these results by demonstrating that treatment of isolated effect was elicited by different NOS inhibitors in different guinea pig cardiomyocytes with endotoxin decreases their experimental settings, such as the rat heart in vitro [48, 65 ] contractile response to electrical field stimulation and that and in vivo [66] and in the dog heart in vivo [67] [68] [69] . The this effect could be reversed by pharmacological inhibition effect of the NOS inhibitors were concentration-dependent of NOS [59] . These investigations strongly indicated the and the maximal reduction of myocardial contractility existence of at least two different isoforms of NOS in varied between 5 and 25%. If endogenous NO production ventricular myocardium. Further detailed studies by Bal- by a constitutive NOS affects myocardial contractility, one ligand et al. [60, 61] in rat isolated cardiomyocytes pro- would suggest that at least a part of these effects are vided evidence for the constitutive expression of eNOS mediated by cGMP generated upon stimulation of soluble and for induction of iNOS expression following treatment guanylate cyclase (Fig. 1) . Recently, a new and specific with cytokines.
inhibitor of soluble guanylate cyclase, the compound Normal cardiomyocytes selectively express eNOS, while ODQ, has become available [70] . The effects of this drug expression of iNOS is detectable only after incubation with on myocardial contractility have been investigated in a various cytokines [10] . These two isoforms of NOS show constant flow perfused Langendorff preparation of the rat several major differences [3] . The activity of eNOS is heart. In these experiments, ODQ induced a marked strictly dependent on the cytosolic calcium concentration reduction of myocardial contractility at a low concentration ? and the enzyme produces NO in nanomolar concentra-(0.1 mM), suggesting that cGMP production stimulated by ? tions. By contrast, iNOS produces NO in the micromolar basal NOS activity supports the development of myocarconcentration range and its activity is not regulated by the dial contraction [48] . Investigations in patients with corcytosolic calcium concentration. The intracellular concenonary artery disease have shown that pharmacological ? tration of NO in cardiomyocytes as an indicator of the inhibition of NOS induces a reduction in cardiac output activity of eNOS is unknown. A recent study in normal that cannot be explained by the concurrent increase in ? isolated rat cardiomyocytes showed a concentration of NO blood pressure, as evidenced by phenylephrine infusions at its cell surface that was below 150 nM [62] . Interesting- [71] . In summary, these studies in animals and man ly, exposure of the cells to b-adrenergic agonists increased provided evidence for the existence of a basal activity of ing cGMP as an indicator for NO production in rat of basal endogenous NO production are not homogeneous. cardiomyocytes showed a ten-fold increase in cGMP levels
Other studies in isolated cardiomyocytes, isolated papillary after stimulation with either bradykinin or acetylcholine muscles and in vivo preparations failed to detect any [63] . These results suggest that several mediators can influence on myocardial contraction or obtained opposite induce a stimulation of basal eNOS activity in carresults. The contraction amplitude of hamster papillary diomyocytes.
muscles decreases with increasing beating rate. Inhibition of NOS enhanced the contractile response of these muscles at any frequency, although the effect declined with increasing beating rates [72] . A similar amplification of the contraction amplitude after inhibition of NOS was observed in isolated rat cardiomyocytes [73] . Another study in the dog heart in vivo reported that the NOS inhibitor G N -monomethyl-L-arginine (L-NMMA) had no effect on baseline myocardial contractility [74] . These results indi-? cate that basal endogenous NO production inhibits rather than supports myocardial contraction. The reason for this apparent discrepancy is unknown. It might be related to species differences or experimental conditions, such as culturing techniques that might influence the basal expression of NOSs, the time point of measurement of contractile effects, the technique of electrical field stimulation, includ- NO (Fig. 1) , varies depending on the species and exof catecholamine. By contrast, the negative inotropic effects of NO are perimental conditions. somewhat more pronounced but occur only at very high concentrations.
Inducible NOS
Myocardial expression of iNOS can be stimulated by spontaneously hypertensive rats with significant hemotreatment with cytokines or E. coli lipopolysaccharide dynamic and humoral signs of severe heart failure and with [58] [59] [60] 64, 75] . Subsequent to iNOS expression, the reacmassive myocardial hypertrophy showed a strongly intivity of the myocardial muscle changes and a decrease in hibited response to catecholamines but a completely ? basal myocardial contractility [59, 75, 76] , a diminished identical response to NO donors and NOS inhibitors response to b-adrenergic stimulation [60, 64] and higher compared to control animals [56] . rate of cell deaths have been observed [77] . These observaIn spite of this apparent diversity, it is attractive to tions suggest that iNOS expression strongly increases the assume that expression and activity of iNOS may be ? intracellular concentration of NO in cardiomyocytes, involved in the development of contractile dysfunction of leading to an inhibition of myocardial contraction. This the ventricular myocardium in different diseases and interpretation is consistent with cardiodepressive effects evidence for this interesting hypothesis has been summa-
?
that occur at high concentrations of exogenous NO (Fig.  rized recently [10, 11, 80] . Accordingly, expression of iNOS 2). A more direct prove of this hypothesis would be the may play a significant role in heart failure or rejection after ? detection of large amounts of NO production in cytokinetransplantation. In transplanted hearts, the reduction of the treated cardiomyocytes [62] .
inotropic response to the b-mimetic dobutamine correlates As already described for eNOS, the results of inveswith the degree of myocardial iNOS expression [81] . tigations on the influence of iNOS on myocardial contracExpression of iNOS has also been detected in different tion are not homogeneous. There is evidence for myocarforms of heart failure, but the results are somewhat dial depression induced by cytokines that could be contradictory. In the human myocardium, a significant abolished by NOS inhibitors, although the effects were expression of iNOS was found in dilatative carobserved after a 30-min incubation period, which almost diomyopathy and myocarditis, as evidenced by histology excludes expression of iNOS as an underlying cause [78] .
and mRNA-level quantitation [82] [83] [84] . However, this The mechanism of this effect of cytokines is not known expression is also detectable in normal human myocardium and there is no evidence that cytokines directly activate [85] and absent in another group of patients with dilatative
NOSs to produce NO. A similar situation seems to hold cardiomyopathy [86] . These data suggest that iNOS is not true for lipopolysaccharide. Treatment of guinea pigs with consistently expressed in the myocardium of heart failure lipopolysaccharide can induce a strong decrease in left patients. Furthermore, the expression and the activity of ? ventricular contractility in the absence of any detectable enzymes involved in the NO-cGMP pathway of the expression of iNOS [79] . Similar results have been obcardiac muscle (Fig. 1 ) might be changed in heart failure tained in an experimental model of heart failure. Isolated [87] . Thus, the role of iNOS expression in heart failure constant flow perfused hearts of aged 'stroke-prone' remains controversial.
? ?
Effects of endogenous NO on myocardial
positive chronotropic effect of exogenous NO is important relaxation in a heart that is beating under autonomic control.
?
The lusitropic action that has been described for exogen- ous NO synthesis [88] . Infusion of bradykinin and subThe first report describing the chronotropic effects of ? stance P elicited a lusitropic effect in the guinea pig endogenous NO was performed with cultured neonatal rat working heart, which was completely abolished by the cardiomyocytes [91] . In this study, the NOS inhibitor ? NO scavenger, oxyhemoglobin. A similar effect was L-NMMA had no significant effect on the spontaneous observed in man. Intracoronary infusion of substance P in beating rate of these cells. In contrast, the NOS inhibitor G the presence of dobutamine was associated with acceler-N -nitro-L-arginine methyl ester (L-NAME) induced a ated myocardial relaxation [89] . The lusitropic effect of considerable reduction of beating rate in constant pressure ? endogenous NO observed in both animals and man are perfused isolated rat hearts and this effect was reversed by ? similar to the lusitropic effects of exogenous NO. L-arginine [93] . The negative chronotropic effect of L-NAME was confirmed in a later study investigating rat constant flow perfused Langendorff preparations [48] . effects of NO in the absence of autonomic stimulation. An NAME to normal mice also results in a significant early study investigated the effects of the cGMP analogue reduction of heart rate [98, 99] . These effects have been dibutyryl-cGMP in cultured rat neonatal cardiomyocytes. measured in awake trained mice using an automated tail Subjection of these cells to high concentrations of dicuff method. Using the same method, it was shown that butyryl-cGMP resulted in a 15% reduction of their spontathree weeks of oral application of L-NAME to mice neous beating rate of approximately 100 beats / min [90] . In lacking the eNOS gene induces an augmentation of their contrast, a later study in this cell type failed to detect any bradycardia [99] . It is of note that the NOS inhibitor ? influence of the NO donors SNP or SIN-1 on the basal L-NAME is also capable of blocking muscarinergic re-? beating rate [91] . Similar results with NO donors were ceptors [100] , an effect that might have attenuated the obtained in isolated rat right atria [92] , while another study observed reduction of heart rate in mice. Taken together, reported that low concentrations of SNP induced an the present evidence suggests that heart rate can be increase in the spontaneous beating rate of the rat isolated increased by the activity of both constitutively expressed heart of approximately 20% [93] . Furthermore, clinical NOS isoforms. Of these, eNOS is much more important investigations in patients after heart transplantation indithan nNOS. These results are consistent with the positive ? cated a direct positive chronotropic effect of NO. Infusion chronotropic effects that have been described and ex-
of SNP increased the heart rate in these patients before plained for exogenous NO. reinnervation of the heart occurs, which strongly speaks against baroreceptor activation as an underlying mechanism [94, 95] rate of this preparation [96] . Low concentrations (10 nMinterest. NO stimulates myocardial soluble guanylate 10 mM) induced a 30% increase in beating rate, while this cyclase to produce cGMP, which activates two major target effect declined at higher concentrations. Both effects were proteins. A small increase in cGMP levels predominantly dependent on cGMP, suggesting a role for soluble inhibits phosphodiesterase III, while high cGMP levels guanylate cyclase in the regulation of heart rate. induce the opposite effects.
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